Clinical trial
Long-Term Observational Study of Translarna Safety and Effectiveness in Usual Care
NCT02369731 is registered in ClinicalTrials.gov with PTC Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-Term Observational Study of Translarna Safety and Effectiveness in Usual Care
- Lead sponsor
- PTC Therapeutics
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2015
- Completion date
- March 31, 2025
- Enrollment
- 316 (actual)
- Sites
- 71
Conditions
As the registry lists them; a condition with its own page is linked.